PLAT and androgen insensitivity syndrome: In the randomized SYNTHESIS Expansion trial, 362 patients with AIS within 4.5 h after onset were randomly assigned to either intravenous tPA or endovascular therapy (intra-arterial thrombolysis with tPA, mechanical clot disruption or retrieval, or a combination of these approaches).